Medscape Oncology

Pharmacogenetic Testing for 5-FU Saves Lives and Money


Listen Later

Prospective screening for a genetic variant of DPD, an enzyme that catabolizes 5-FU, reduces mortality from 10% to 0% in patients with this variant and is cost-effective. Dr David Kerr is all for it.
...more
View all episodesView all episodes
Download on the App Store

Medscape OncologyBy Medscape